"iil"

Anger is rising over India’s drug regulators for failing to issue a public advisory on counterfeit Abhayrab rabies vaccines. Despite alerts from Indian Immunologicals Limited, authorities chose a quiet probe, prompting ethical concerns after global warnings were issued by foreign regulators.

Fake anti-rabies vaccines detected in India trigger global alerts as US, UK and Australia track travellers and supply chain failures.

Dr K Anand Kumar, MD, IIL, said, “we are the first in India to get to fish vaccines and are covering different kind of fishes and culture conditions."

Hyderabad-based vaccine maker implements expansion across multiple facilities in Hyderabad and Bengaluru to reach about 700 million doses per year capacity

Hyderabad-headquartered biologicals company setting up new viral antigen plant at Karkapatla in Telangana to cater to viral vaccines and opens new sterile filling facility